Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
NovaBay Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative, non-antibiotic, anti-infective products. Their portfolio targets the unmet therapeutic needs in the eyecare, wound care, and dermatology markets. Key products include Avenova® for lid and lash hygiene, NeutroPhase® for advanced wound care, and CelleRx® for cosmetic skincare. NovaBay focuses on leveraging its proprietary Aganocide® compounds, which are stable, pure, and proprietary formulations of hypochlorous acid (HOCl).
Serves as the central hub for corporate leadership, strategic planning, research and development oversight, financial operations, and commercial activities for NovaBay's product lines.
Located in a modern multi-tenant office tower in Emeryville, providing access to a vibrant biotech ecosystem. Specific internal architectural details are not publicly highlighted.
NovaBay likely fosters a lean, agile, and science-driven work environment, emphasizing innovation and collaboration, which is typical for smaller biopharmaceutical companies focused on bringing novel products to market.
The headquarters' strategic location in Emeryville, part of the San Francisco Bay Area biotech cluster, facilitates access to specialized talent, research institutions, potential partners, and investors.
NovaBay Pharmaceuticals primarily focuses its commercial operations within the United States, where its flagship product Avenova® is marketed and sold. While its direct operational footprint is U.S.-centric, its products like NeutroPhase® may have distribution partnerships that extend its reach internationally in specific markets. The company's research and development activities, while managed from the U.S., may involve global collaborations or sourcing.
2000 Powell Street, Suite 1150
Emeryville
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NovaBay Pharmaceuticals' leadership includes:
NovaBay Pharmaceuticals has been backed by several prominent investors over the years, including:
In the past 12 months, NovaBay Pharmaceuticals experienced a key transition in its finance leadership, with the resignation of its CFO and the subsequent appointment of its Controller as Interim CFO.
Discover the tools NovaBay Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NovaBay Pharmaceuticals likely utilizes a common corporate email format. Based on standard industry practices for companies of its size, the most probable format is the first initial followed by the last name.
flast@novabay.com (e.g., jsmith@novabay.com)
Format
jhall@novabay.com
Example
75%
Success rate
GlobeNewswire • May 15, 2024
NovaBay announced its financial results for the first quarter ended March 31, 2024, highlighting Avenova sales and ongoing commercial strategies....more
GlobeNewswire • May 10, 2024
NovaBay announced that Audrey Kunis resigned as Chief Financial Officer, and Tommy Law, the Company’s Controller, was appointed Interim Chief Financial Officer, effective May 9, 2024....more
GlobeNewswire • January 29, 2024
NovaBay announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Avenova® Allograft, an amniotic membrane for ophthalmic use, and its immediate U.S. launch....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NovaBay Pharmaceuticals, are just a search away.